Literature DB >> 30875062

Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study.

C Zheng1, F Jiang2, H Lin3, S Li4.   

Abstract

PURPOSE: Emerging data have shown that patients with left-sided cancers have better survival than patients with right-sided cancers in terms of metastatic colorectal cancer. However, the available information and findings remain limited and contradictory in localized colorectal cancer. This study aimed to evaluate the clinical characteristics and prognosis of primary tumor location (PTL) in colorectal cancer.
METHODS: Patients' diagnoses were identified using the Surveillance, Epidemiology, and End Result database between 2006 and 2015. The analyses were further stipulated to patients with primary cancer site, histology, and stage information. The correlations between PTL and overall survival (OS) were assessed.
RESULTS: Compared with left-sided tumors, right-sided tumors were more likely to develop into T3 cancers (50.0% vs. 44.8%), T4 cancers (15.8% vs. 12.3%), mucinous or mucin-producing adenocarcinoma (10.8% vs. 5.0%), and signet ring cell carcinoma (1.4% vs. 0.7%), P < 0.01, respectively. Patients with right-sided tumors showed inferior OS (56.1% vs. 60.2%), and the hazard ratio was 1.224 (95% CI, 1.208-1.241, P < 0.001) in all stages. Stage-specific Cox regression analysis revealed that patients with right-sided tumors also showed inferior OS in every stage (respectively, P < 0.05) than left-sided tumors.
CONCLUSIONS: This study demonstrated that the prognoses of patients with left-sided cancers were better than those of patients with right-sided cancers regardless of stage. PTL can be a prognosis factor in colorectal cancer. We encourage developing clinical and translational studies to elucidate the causative relationship between PTL and prognosis.

Entities:  

Keywords:  Colorectal cancer; Overall survival; Primary tumor location; Prognosis

Mesh:

Year:  2019        PMID: 30875062     DOI: 10.1007/s12094-019-02083-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  30 in total

1.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

2.  Distinct metastatic patterns in colorectal cancer patients based on primary tumour location.

Authors:  Niek Hugen; Iris D Nagtegaal
Journal:  Eur J Cancer       Date:  2017-02-16       Impact factor: 9.162

3.  Impact of Primary Tumor Location on First-line Bevacizumab or Cetuximab in Metastatic Colorectal Cancer.

Authors:  Matthew Snyder; Sal Bottiglieri; Khaldoun Almhanna
Journal:  Rev Recent Clin Trials       Date:  2018

4.  The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials.

Authors:  Julian Walter Holch; Ingrid Ricard; Sebastian Stintzing; Dominik Paul Modest; Volker Heinemann
Journal:  Eur J Cancer       Date:  2016-11-29       Impact factor: 9.162

5.  Primary tumor location as a prognostic factor in metastatic colorectal cancer.

Authors:  Fotios Loupakis; Dongyun Yang; Linda Yau; Shibao Feng; Chiara Cremolini; Wu Zhang; Martin K H Maus; Carlotta Antoniotti; Christiane Langer; Stefan J Scherer; Thomas Müller; Herbert I Hurwitz; Leonard Saltz; Alfredo Falcone; Heinz-Josef Lenz
Journal:  J Natl Cancer Inst       Date:  2015-02-24       Impact factor: 13.506

6.  Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.

Authors:  Yakup Kulu; Ignazio Tarantino; Adrian T Billeter; Markus K Diener; Thomas Schmidt; Markus W Büchler; Alexis Ulrich
Journal:  Ann Surg Oncol       Date:  2015-08-25       Impact factor: 5.344

Review 7.  Are there two sides to colorectal cancer?

Authors:  Barry Iacopetta
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  The consensus molecular subtypes of colorectal cancer.

Authors:  Justin Guinney; Rodrigo Dienstmann; Xin Wang; Aurélien de Reyniès; Andreas Schlicker; Charlotte Soneson; Laetitia Marisa; Paul Roepman; Gift Nyamundanda; Paolo Angelino; Brian M Bot; Jeffrey S Morris; Iris M Simon; Sarah Gerster; Evelyn Fessler; Felipe De Sousa E Melo; Edoardo Missiaglia; Hena Ramay; David Barras; Krisztian Homicsko; Dipen Maru; Ganiraju C Manyam; Bradley Broom; Valerie Boige; Beatriz Perez-Villamil; Ted Laderas; Ramon Salazar; Joe W Gray; Douglas Hanahan; Josep Tabernero; Rene Bernards; Stephen H Friend; Pierre Laurent-Puig; Jan Paul Medema; Anguraj Sadanandam; Lodewyk Wessels; Mauro Delorenzi; Scott Kopetz; Louis Vermeulen; Sabine Tejpar
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

10.  Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.

Authors:  Yongjun Cha; Kyung-Ju Kim; Sae-Won Han; Ye Young Rhee; Jeong Mo Bae; Xianyu Wen; Nam-Yun Cho; Dae-Won Lee; Kyung-Hun Lee; Tae-Yong Kim; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Seung-Yong Jeong; Kyu Joo Park; Gyeong Hoon Kang; Tae-You Kim
Journal:  Br J Cancer       Date:  2016-06-16       Impact factor: 7.640

View more
  15 in total

1.  Risk of colon cancer-related death in people who had cancer in the past.

Authors:  Jing Shi; Yingmei Li; Wei Song; Mingxue Wang; Linyu Zhang; Haobin Lian; Zhi He; Nijun Wei; Zilong Zheng; Juan Wen
Journal:  Int J Colorectal Dis       Date:  2022-07-07       Impact factor: 2.796

2.  A nine-gene signature to improve prognosis prediction of colon carcinoma.

Authors:  Jinlai Zhao; Yigang Wang; Jianchao Gao; Yang Wang; Xuan Zhong; Xiaotang Wu; Hua Li
Journal:  Cell Cycle       Date:  2021-05-14       Impact factor: 4.534

3.  Upregulated long intergenic non-protein coding RNA 1094 (LINC01094) is linked to poor prognosis and alteration of cell function in colorectal cancer.

Authors:  Guangliang Zhang; Yingjie Gao; Zhen Yu; Hui Su
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  Nomogram for predicting overall survival in colorectal cancer with distant metastasis.

Authors:  Zheng Liu; Yao Xu; Guijun Xu; Vladimir P Baklaushev; Vladimir P Chekhonin; Karl Peltzer; Wenjuan Ma; Xin Wang; Guowen Wang; Chao Zhang
Journal:  BMC Gastroenterol       Date:  2021-03-04       Impact factor: 3.067

5.  MiR-1539 and Its Potential Role as a Novel Biomarker for Colorectal Cancer.

Authors:  Xueyang Cui; Zhi Lv; Hanxi Ding; Chengzhong Xing; Yuan Yuan
Journal:  Front Oncol       Date:  2021-02-18       Impact factor: 6.244

6.  Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases.

Authors:  E S Bergen; P Scherleitner; P Ferreira; B Kiesel; C Müller; G Widhalm; K Dieckmann; G Prager; M Preusser; A S Berghoff
Journal:  ESMO Open       Date:  2021-06-04

7.  The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer.

Authors:  Hou-Qun Ying; Fan Sun; Yu-Cui Liao; Dan Cai; Ying Yang; Xue-Xin Cheng
Journal:  Ther Adv Med Oncol       Date:  2021-06-28       Impact factor: 8.168

8.  The Prognostic Value of New Index (LANR) Composed of Pre-operative Lymphocytes, Albumin, and Neutrophils in Patients With Resectable Colorectal Cancer.

Authors:  Xinjun Liang; Shuang Yao; Ping Lu; Yifei Ma; Hongli Xu; Zhucheng Yin; Junjie Hu; Yanyan Liu; Shaozhong Wei
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

9.  Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer.

Authors:  Yang Xi; Pan Yuefen; Wu Wei; Qi Quan; Zhuang Jing; Xu Jiamin; Han Shuwen
Journal:  J Transl Med       Date:  2019-10-29       Impact factor: 5.531

Review 10.  Pathological Features and Prognostication in Colorectal Cancer.

Authors:  Kabytto Chen; Geoffrey Collins; Henry Wang; James Wei Tatt Toh
Journal:  Curr Oncol       Date:  2021-12-13       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.